Ownership history in Caption Management, LLC · 59 quarters on record
This page tracks every 13F SEC filing in which Caption Management, LLC reported a position in NEUROCRINE BIOSCIENCES INC (NBIX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 35,000 | +5,000 | +16.7% | 0.03% | $5.0M | $141.83 |
| 2025 Q3 | REDUCED | 30,000 | -23,000 | -43.4% | 0.03% | $4.2M | $140.38 |
| 2025 Q3 | ADDED | 53,000 | +23,000 | +76.7% | 0.06% | $7.4M | $140.38 |
| 2025 Q2 | REDUCED | 30,000 | -10,000 | -25.0% | 0.04% | $3.8M | $125.69 |
As of 2025 Q4 — sorted by position size